Sun Pharma Seeks Approval for $1 Billion Related-Party Transactions in FY26

On Thursday, Sun Pharmaceutical Industries announced that it has requested shareholders' consent for related-party transactions (RPTs) totaling about $1 billion for FY26...

UK-India partnership unveils 'Living Lab' for Sustainable Pharma Manufacturing

A groundbreaking UK-India initiative, the ‘Living Laboratory’ was officially launched in Pune, India, marking a significant step toward decarbonizing the pharma industry. The state-of-the-art facility that will serve as a

Innocan Pharma Obtains Indian Patent for Liposome-Based CBD Drug

Innocan Pharma Corporation, a leader in the pharmaceutical and biotechnology sectors, is pleased to declare that it has received a patent in India for a prolonged-release pharmaceutical formulation that uses liposomes to encapsulate cannabinoids...

Pharma Firms Directed to Update MRP by NPPA post Budget 2025 Duty Exemptions

The maximum retail price (MRP) of medications and formulations that are no longer subject to customs duty has been adjusted by the National Pharmaceutical Pricing Authority (NPPA) in accordance with this year's budget.

Aurobindo Pharma Secures EC Approval for Marketing Zefylti

Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the European Union (EU) for Zefylti, a filgrastim biosimilar, to CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of the Company....

Pharmaceutical Bodies Recommend Concessions on Medical Exports

In the context of ongoing US-India discussions on tariffs, key pharmaceutical industry bodies in India—Pharmaceuticals Exports Promotion Council (Pharmexcil), Indian Pharmaceutical Association (IPA), and Indian Drug Manufacturers Association (IDMA...

Indian Pharma Companies Unaffected by Trump's Trade Tariffs

Indian companies in the pharmaceutical and steel sectors remain largely unaffected by the Trump administration’s impending trade tariffs, with industry leaders downplaying concerns about their impact on Indian exports to the US.

Aurobindo Pharma to Commence Operations of Latest Chinese Facility

Aurobindo Pharma will commence supplies to Europe from its China facility from April onwards, according to Chief Financial Officer Santhanam Subramanian. The Hyderabad-based drug maker commenced operations at the facility in the last week of Novem...

KKR Slated to Acquire HCG Cancer Care Hospital Chain

Global private equity giant KKR is set to acquire a controlling 51% stake in Healthcare Global Enterprises (HCG), a leading Bengaluru-based cancer care hospital chain, from CVC Capital Partners, according to sources familiar with the deal. This mo...

USAID Freeze Halts Circulation of Life-Saving Drugs Across the Globe

Hundreds of millions of dollars' worth of life-saving medical supplies are stranded in warehouses and on ships worldwide due to former U.S. President Donald Trump's decision to freeze foreign aid, sources familiar with the humanitarian program tol...

© 2025 India Pharma Outlook. All Rights Reserved.